Valeant Pharmaceuticals (VRX) gains 11.3% today on good news.VRX had been consolidating since October of last year. We bought a position last week when it hit our buy point. VRX represented a 20% position in the Core Equities Folio.
Valeant Pharma
 |
| Up 11.3% Today |
After a weak start to 2014, the market rebounded today.
This blog post does not constitute an offer of investment advice. This blog is only provided for educational purposes. Please read the Important Blog Disclosure posted in the right channel bar.
No comments:
Post a Comment